The US Department of Veterans Affairs (VA) Gulf War Era Cohort and Biorepository (GWECB) is a nationally representative longitudinal cohort of US veterans who served during the 1990-1991 Gulf War era. The GWECB combines survey data, such as demographic, health behavior, and environmental exposure data; medical records; and a linked biorepository of blood specimens that can support a broad range of future research regarding health concerns unique to veterans of this era. To build this resource, the VA Cooperative Studies Program initiated a pilot study (2014)(2015)(2016) to establish the GWECB and evaluate the processes required to build and maintain the resource. Participants (n = 1,275) consented to future sharing of their data and biospecimens for research purposes. Here we describe the pilot study, including recruitment and enrollment procedures, data collection and management, quality control, and challenges experienced. The GWECB data available to investigators under approved sharing mechanisms and the procedures for accessing them are extensively detailed. The study's consenting documents and a website link for the research survey are provided. Our hope is that new research drawing on the GWECB data and biospecimens will result in effective treatments and improved approaches to address the health concerns of Gulf War-era veterans.
During the 1990-1991 Gulf War, nearly 700,000 members of the US Armed Forces were deployed to Southwest Asia. An additional 4 million personnel were deployed elsewhere or remained stateside. It is recognized that deployed veterans of this era have increased prevalence of reported health conditions and symptoms in musculoskeletal, neurological, pulmonary, gastrointestinal, and dermatological systems when compared with veterans who did not deploy (1) (2) (3) (4) , but with equivalent or lower disease-related mortality (1) (2) (3) (4) (5) (6) . For this reason, the US Departments of Veterans Affairs (VA), Defense, and Health and Human Services have funded over 500 research projects pertaining to the health consequences of military service during the 1990-1991 Gulf War (Victor Kalasinsky, VA Office of Research and Development, personal communication, 2018).
While past research represents a tremendous investment in understanding the medical conditions of veterans from the 1990-1991 Gulf War era, many important questions about the current and future health concerns of this population remain. Additionally, as these veterans approach the age range (approximately 45-60 years) at which the incidence of chronic disease increases rapidly (7) , there are new questions about the relationship of age-related chronic diseases to the illness burden carried by this population.
To facilitate these investigations, the VA's Cooperative Studies Program created the Gulf War Era Cohort and Biorepository (GWECB), a longitudinal cohort of veterans of the 1990-1991 Gulf War era that combines survey data, medical records, and a linked biorepository of blood specimens. The GWECB was created under a regulatory framework that permits data and specimens to be shared with investigators who want to study health conditions affecting veterans of this age group or service era.
The scope and design of the GWECB was informed by existing longitudinal, population-based research cohorts, such as the National Cohort of Gulf War and Gulf War Era Veterans (8, 9) ; the Fort Devens Operation Desert Storm cohort (10) (11) (12) ; and the Iowa Persian Gulf War cohort (2) . These and other Gulf War research cohorts included the administration of surveys, in-person clinical evaluations, and blood collection (13, 14) and enabled abundant research to better understand the health conditions of this population. Most of these cohorts included both veterans who receive VA health care and those who do not, but no cohort investigators linked survey and clinical data with biospecimens at enrollment, and many focused exclusively on veterans who were deployed to the Persian Gulf region. The GWECB adds value to this collection of cohorts by: providing linked biospecimens and data; emphasizing the inclusion of veterans who do not use the VA for their health care; and including both deployed and nondeployed veterans. Further, unlike some earlier research cohorts, the GWECB complies with current privacy and biospecimen-sharing regulations that allow secondary data use and participant recontact.
Prior to launching a full-scale GWECB development effort, the VA Cooperative Studies Program initiated a pilot study (2014) (2015) (2016) ) that aimed to establish the research cohort and biorepository on a smaller scale and evaluate the processes required to build and maintain the resource, including recruitment, consent, blood collection, and database development. Because of a low response rate during the pilot study, the VA will not proceed with full-scale development of the GWECB. Nonetheless, an important research resource was established. Our aims in this article are to describe the pilot study GWECB development process, the data currently available to investigators, and the process for data access for future research. This future research can inform the development of interventions designed to improve diagnosis, treatment, and outcomes of care for veterans of the 1990-1991 Gulf War era.
METHODS

Study population
Veterans were eligible to participate in the GWECB if they had served in the US Uniformed Services during the period August 1990-July 1991, regardless of deployment or combat status, health status, or whether they had enrolled in and/or used the Veterans Health Administration (VHA) for their health care ("VHA users") or not ("VHA nonusers"). The pilot study recruitment sample was based on a stratified random sample (panel) of 90,000 veterans from the 1990-1991 Gulf War era. The stratified recruitment panel was obtained from the Department of Defense Manpower Data Center and was drawn from a total population of 4,966,117 veterans who served during August 1990-July 1991. The panel included VHA users and nonusers within 6 stratification factors: 1) deployment "in theater," or in an area where combat-related activities were occurring (50%); 2) active duty (50%); 3) Army (50%); 4) grade of officer (10%); 5) nonwhite race, which included American Indian, Asian, black, other, and unknown (20%); and 6) nonmale sex, which included female and unknown (20%).
National locator searches were performed to update contact information and vital status for veterans in the recruitment panel. Veterans were selected for inclusion in the pilot study recruitment sample (n = 10,042) according to vital status, availability of valid contact information, and geographic location within the contiguous United States (Figure 1 ). The pilot sample was constructed to frequency-match the geographic distribution of the recruitment panel across the 4 US Census regions, reflecting geographic variation in the veteran population. Within Census regions, cities were selected as recruitment hubs according to the local availability of contracted phlebotomists and other study staff. This sampling and pragmatic implementation contributed to regional variation in recruitment. Veterans meeting eligibility criteria could also self-nominate for participation; these veterans heard about the GWECB via social media, local events, word of mouth, and other channels.
Data collection
Recruitment. Veterans in the pilot recruitment sample and those who self-nominated were mailed an invitation packet, which included the Gulf War Era Veterans' Survey, informational and consent documents, and an opt-out postcard (15; see the Web Appendix, available at https://academic.oup.com/aje). Veterans interested in participation were required to contact the GWECB Enrollment Coordinating Center by telephone before completing study documents. One to 3 weeks after the invitation packet was mailed, the Enrollment Coordinating Center began follow-up calls. If the call center was unsuccessful at reaching the veteran after several attempted calls and voice messages, a second invitation packet was mailed. The veteran was then added to the call center queue for a second and final round of follow-up calls.
Once telephone contact had been made, an enrollment coordinator confirmed eligibility and obtained informed consent. Participants were instructed to sign and return the consent documents and survey in a postage-paid return envelope. The consent documents included permissions for: review of VA and non-VA medical records; access to data and blood from VA and non-VA studies in which they participated; access to information from VA and Department of Defense databases, biorepositories, and registries; use of their data and/or blood sample for future research; recontact to update survey responses and contact information; and recontact about participation in future research projects (Web Appendix). Once the completed consent documents and survey had been received and reviewed by the Enrollment Coordinating Center, a blood collection appointment was scheduled. All consent documents, the survey, and blood collection were required for full enrollment in the GWECB. Participants did not have the option to partially enroll, though veterans who did not complete all requirements were assigned this status if they provided permission for, at minimum, recontact and future access to and use of data.
Blood collection, processing, and storage. A contracted phlebotomist traveled to the participant's home or other convenient private location to collect a blood specimen. One 10-mL ethylenediaminetetraacetic acid tube of whole blood was collected from each participant. The specimen was shipped overnight to the VA genomic medicine biorepository (VA Central Biorepository at the Massachusetts Veterans Epidemiology Research and Information Center); upon receipt, blood was centrifuged at 2,000 × g for 15 minutes at 4°C, and aliquots of plasma and buffy coat were prepared. An aliquot of cells was used to extract genomic DNA using the Agencourt Genfind v2 DNA extraction system (Beckman Coulter Life Sciences, Indianapolis, Indiana). After extraction, the laboratory used NanoDrop Ultraviolet-Visible spectrophotometers (Thermo Fisher Scientific, Waltham, Massachusetts) to quantify the quality and purity of the isolated DNA. Extracted DNA, buffy coats, and plasma were frozen and stored at −80°C for future research use.
Survey instrument. The Gulf War Era Veterans' Survey (15; Web Table 1 ) was developed in collaboration with several researchers and clinicians experienced in conducting studies with veterans from the 1990-1991 Gulf War era. Survey development was performed with 3 goals: 1) inclusion of the VA Million Veteran Program (16) baseline questionnaire, for consistency with other VA research projects; 2) inclusion of survey items pertinent to the health concerns of Gulf War-era veterans (e.g., deployment location and exposure experience); and 3) less than 1 hour required for completion. The survey assessed military service history; lifestyle and other behaviors; physical and mental health (including some health symptom severity, frequency, and functional impact characteristics); and the health histories of the participant's biological firstand second-degree relatives. When available, validated instruments and other measures previously used in Gulf War research were chosen (13) . To evaluate usability, the survey was tested through 2 rounds of cognitive interviews with veterans from the 1990-1991 Gulf War era (n = 17) and was revised on the basis of veterans' feedback prior to launching the pilot study (17) .
Data quality and management
Survey development and quality assurance. The GWECB survey was developed and processed with an emphasis on quality and reliability. The survey was created using the TeleForm Enterprise software application, version 10.7 (Cardiff Software, Vista, California) to allow digital capture of data from scanned participant forms. Prior to mailings, a set of test surveys was completed with a range of incorrect marks and completion styles to permit scanner testing and identify changes necessary to reduce layout-related scanning errors. Once surveys had been received from participants, they were scanned and processed using optical character recognition. Indeterminate and write-in values were flagged for later resolution. The data were written to a relational database, using reason codes to classify missing answers, multiple answers, and invalid values. Complete manual quality assurance checks were performed on the first 100 surveys received and on all additional surveys containing data that required the use of reason codes, using an automated, auditable system.
The quality assurance application and other internal data validation software were developed using automatically generated software code that drew on structured information about the project's database contents (metadata). This ensured that any changes to the data collection would immediately propagate through all databases, quality control software, and associated project materials (18) .
Ongoing cohort maintenance. The GWECB project team will maintain cohort information over time via periodic updates to participant contact information, vital status, survey data, and health-care provider information.
Statistical analysis. Descriptive statistics for each reported survey item were obtained for the full data set. In light of our goal of including VHA nonusers and users, we also present descriptive statistics by user status. Mean values and standard deviations or frequencies and percentages were calculated for continuous or categorical variables, respectively. Data management and statistical analyses were performed using SAS, version 9.4 (SAS Institute, Inc., Cary, North Carolina).
Regulatory approvals. The study protocol and all study materials were approved by the VA Central Institutional Review Board and acknowledged by the Durham VA Medical Center Research and Development Committee. The ClinicalTrials. gov identifier is NCT01803854.
RESULTS
During the pilot study (September 2014 through May 2016), recruitment materials were mailed to 10,210 veterans (10,042 from the stratified recruitment panel and 168 who self-nominated). The GWECB final enrollment included 1,275 (12.5%) "fully enrolled" veterans who completed all study requirements: 3 consenting documents (Web Appendix), the GWECB survey (15) , and a blood sample ( Figure 1 ). A total of 71 (5.6%) veterans in the final cohort had self-nominated. Several veterans only partially completed study requirements and were not considered part of the fully enrolled sample; however, some data for these veterans were also available. For example, of all veterans contacted, 69 (0.7%) completed the required consent documents and the survey but did not provide a blood sample; that is, 1,344 (13.2%) veterans consented to at least recontact and accessing health and survey information.
A total of 886 (69.5%) fully enrolled veterans consented to permitting access to non-VA medical records and provided information about their non-VA medical providers since 1989 using a study form (Web Appendix). Veterans included varying amounts of information for the following fields: non-VA provider name, address, telephone number, and fax number; years of care; and type of care (inpatient or outpatient). These medical records were not obtained as part of the pilot study but can be requested in the future.
Blood specimens
A total of 1,275 specimens were collected and processed by the VA genomic medicine biorepository. Of these, 1,274 specimens (99.9%) were received in analyzable condition; 41 (3.2%) were visibly lipemic or hemolyzed, and 16 (1.3%) contained less than the full 8-mL collection volume. The average quantity of DNA extracted per specimen was 13.9 (standard deviation, 5.2) μg, with excellent DNA quality metrics. The average DNA quality ratio (260 nm/280 nm) was 1.88 (optimum ratio, 1.80-2.00), and the average DNA purity ratio (260 nm/230 nm) was 2.13 (optimum ratio, 2.00-2.20).
GWECB participant characteristics
Geographic distribution and demographic characteristics.
The geographic distribution of fully enrolled veterans ("participants") is shown in Figure 2 . Regional variation in enrollment is attributable to the underlying distribution of veterans across the United States (19) and implementation of enrollment hubs that were selected on the basis of study staff availability. Self-reported demographic and military service characteristics are provided in Table 1 , stratified by VHA user status (self-reported use during the year prior to survey completion). The cohort was approximately 76% male and 72% white, with a median age of 53.0 years at enrollment. A total of 679 participants (53.3%) were VHA nonusers, 584 (45.8%) were VHA users, and 12 (0.9%) did not respond to the questions used to make this determination. Almost 71% of participants (69.7% of nonusers, 71.6% of users) reported deployment to the Persian Gulf region in support of the 1990-1991 Gulf War, with the Army being the most common branch of service (52.4%). Overall, the cohort was highly educated; the majority of participants (66.4%) reported completing some college or a bachelor's degree, and 25.6% of VHA nonusers and 15.2% of VHA users reported completing a master's, professional, or doctoral degree. Additionally, 75.8% of VHA nonusers and 53.8% of VHA users reported working full-or part-time.
Web Table 2 provides a summary of demographic and military service characteristics for the full population of veterans in the Uniformed Services during August 1990-July 1991, the GWECB stratified recruitment panel, the pilot recruitment sample, and fully enrolled participants. The final, fully enrolled cohort had a slight overrepresentation of veterans in the female, nonwhite, Army, and active duty sampling strata, relative to the stratified recruitment panel. The final cohort also included many more veterans who were deployed to the Persian Gulf region in support of the 1990-1991 Gulf War (70.6%), as compared with the stratified recruitment panel (50.0%). Both the stratified recruitment panel and the final enrolled cohort varied (because of stratified sampling) from the full population.
Self-reported exposures in deployed participants. Table 2 gives the prevalences of self-reported exposure to wartime substances among participants who deployed to the Persian Gulf region during 1990-1991 (n = 900). Of these veterans, approximately 45% reported entering Kuwait, and 38% reported entering Iraq. The most commonly reported exposures were smoke from oilwell fires (60.0%) and use of pyridostigmine bromide (antinerve agent) pills (57.0%). A total of 53.0% reported having been exposed to pesticides in creams or liquids, uniforms, or insect baits. Approximately 39% reported 5 or more exposures, and just over 2% reported that they had experienced none of the Gulf region exposures listed in Table 2 . An expanded table with all responses for exposures is provided in Web Table 3 .
Self-reported symptoms and health conditions. GWECB participants provided information about their current lifestyle, physical and mental health, and health history and medication use. Participants reported a median of 14 symptoms that had been persistent or recurring over the last 6 months (range, 0-34 symptoms; Table 3 ). Noting our goal of engaging both VHA nonusers and users, we describe health symptoms and conditions for both VHA user status groups. Symptoms reported most frequently overall were: stiffness in joints (68.5% of nonusers, 83.7% of users); pain in joints (69.7% of nonusers, 81.7% of users); not feeling rested after sleep (61.3% of nonusers, 74.5% of users); problems getting to sleep or staying asleep (58.6% of nonusers, 75.3% of users); fatigue (54.6% of nonusers, 69.7% of users); and pain in muscles (49.3% of nonusers, 73.3% of users). A total of 0.9% of participants reported experiencing all of the symptoms surveyed, and 2.8% reported experiencing none. An expanded table with all responses for symptoms is provided in Web Table 4 .
The most frequently reported medical diagnoses for organ systems or health domains are provided in Table 4 ; the tabulation of all surveyed diagnoses is provided in Web Table 5 (both tables exclude written-in "other, please specify" diagnoses). Participants reported a median of 6 medically diagnosed conditions (range, 0-26 conditions), and fewer than 3% of participants reported having none of the 77 conditions surveyed. When summarized by system/domain, veterans reported the most conditions within the circulatory (70.1%), musculoskeletal (55.4%), digestive (50.4%), and nervous (46.4%) systems. Among VHA nonusers, the most commonly reported diagnoses were high cholesterol (44.9%), hypertension (39.5%), and gastroesophageal reflux disease (28.9%). Similarly, among VHA users, the most commonly reported diagnoses were high cholesterol (57.7%), hypertension (54.8%), and depression (43.3%). Additional diagnoses that were not among the most frequently reported overall but which may be of interest within the Gulf War research community included gastroesophageal reflux disease (35.1%), sleep apnea (29.6%), other (nonmigraine) headaches (22.8%), skin conditions (20.1%), migraine headaches (19.4%), and osteoarthritis (18.3%). Participants were also invited to report diagnoses that were not specifically surveyed. Fibromyalgia (1.9%), diverticulitis (2.2%), and hypothyroidism (6.7%) were among the most frequently written-in conditions.
DISCUSSION
Significance of findings
Through collection of extensive individual-level information about medical history, current health conditions, lifestyle factors, and deployment-related exposure history, as well as blood specimens, we have created a new resource for collaborative clinical and epidemiologic research on the health issues of veterans from the 1990-1991 Gulf War era. This resource was built on best practices for data management and sharing to support easy access and widespread use under approved protocols. It is our hope that this linked repository of data and biospecimens will facilitate the discovery of new treatments and approaches (e.g., using molecular phenotyping and therapeutic target identification) to better understand and address the pervasive health concerns of veterans of the 1990-1991 Gulf War era. In addition, the establishment of this cohort within a stratified random sample (Web Table 2 ) that includes both VHA nonusers and users will support valid epidemiologic inference to the Gulf War-era population through the application of sampling weights during analysis. Recognized priority domains include comparisons of health conditions by deployment status and exposure profile; identification of patterns of symptom clustering; and description of health-care utilization patterns to inform policies regarding postdeployment health care.
The GWECB development process
We implemented a number of innovative and quality-driven approaches during the pilot study. For example, in response to the low pilot study enrollment rate (12.5%), the GWECB team initiated a qualitative research activity and conducted interviews and focus groups with veterans of the 1990-1991 Gulf War era and subject matter experts (Mary E. Grewe, VA Cooperative Studies Program Epidemiology Center-Durham, unpublished manuscript, 2018). The goal of this investigation was to better understand veteran perspectives regarding facilitators and barriers to participating in VA research projects such as the GWECB. This work yielded valuable insights for enhancing recruitment outcomes with these and other veterans. Findings h The survey question pertaining to this characteristic allowed for more than one response (e.g., "check all that apply"); thus, numbers may not sum to column totals.
i Includes Chinese, Japanese, Asian Indian, other Asian, and Filipino. j Includes Coast Guard, Merchant Marines, National Oceanic and Atmospheric Administration, and Public Health Service.
k "Currently partnered" includes survey responses for "married," "civil commitment," and "cohabitating"; "formerly partnered" includes responses for "separated," "divorced," and "widowed"; "not partnered" includes responses for "never married." of this qualitative research can be used to support planning and enhance recruitment outcomes for future VA studies.
Further, the GWECB investigators made a strong effort to include both users and nonusers of VHA health-care services. Because users of the VA health-care system are administratively associated with the VA, identifying and contacting these veterans is relatively straightforward. Thus, many VA research studies focus their recruitment efforts on VHA users. This approach limits our understanding of the health experiences of veterans who receive care outside of the VHA and may not allow generalizable conclusions regarding the health of the broader veteran population. Because VHA nonusers represent a large fraction of the deployed 1990-1991 Gulf War-era veteran population (20) , the GWECB relied on historically nontraditional, field-based (vs. clinic-based) approaches to enable enrollment of both VHA nonusers and users. This strategy was successful in reaching the nonuser population, resulting in nearly equal fractions of nonusers and users who demonstrate rich diversity in their histories of military exposures, demographic characteristics, and clinical symptoms and conditions. This study will thus add to the limited but immensely valuable literature on population-based veteran cohort development.
Finally, the GWECB survey items were carefully selected to be compatible with other concurrent and historical veteran population cohorts; were chosen by an expert panel of scientific and clinical subject matter experts; and remained faithful to the original instruments chosen (Web Table 1 ) to retain validity and reliability. These characteristics will facilitate scientifically sound comparisons, phenotype explorations, future research collaborations, and community-wide data harmonization.
The GWECB also integrated evolving standards for data stewardship to ensure that the data from this project are of high quality, well-documented, and easily interpreted by researchers. Data quality assessment practices included ongoing quality control of data collection (resulting in an estimated TeleForm scan error rate of <0.2%), data error coding that retained all raw data values, and a comprehensive auditability and reproducibility plan.
Limitations
The GWECB investigators aimed to recruit adequate numbers of VHA users and nonusers through stratified random sampling, self-nomination, and field-based recruitment and biospecimen collection. While the enrolled cohort generally matched the larger stratified random sample with regard to demographic factors, the enrollment rate was low and substantially overrepresented veterans who deployed to the Persian The original wording from the survey is shown. Twenty-five participants responded to this question but did not respond "yes, deployed to the Gulf " on a previous question; their responses are not included in this table.
c Nine participants who deployed to the Persian Gulf region did not respond to the survey questions used to determine VHA user status; their responses are captured in the "total" column.
d Percentages were calculated relative to all participants, such that the denominator (n = 900) included missing data. See Web Table 3 for a comprehensive tabulation of the survey responses, including frequencies of missing data.
e "Total" includes the number and percentage of participants who responded "yes" to at least 1 of the 3 specific pesticide-related questions.
Gulf theater. It is thus likely that veterans who enrolled had different clinical characteristics than those who did not, creating selection bias in the enrolled cohort and limiting the generalizability of findings regarding the prevalence of specific conditions in the Gulf War-era veteran population (21, 22) . Additionally, the low enrollment rate was a primary driver of the decision to not pursue full-scale development of the GWECB.
As with other cohorts in this population, service-related exposures were self-reported, which may have contributed to recall bias. Health conditions and diagnoses were also self-reported and thus subject to biases of inclusion and selective over-or underreporting, including survivorship bias. Further, our current categorization of veterans by VHA user status is based on self-report of VHA use within the year prior to taking the survey, which may not reflect historical usage. The incorporation of VA electronic medical records could permit corroboration of these self-reported characteristics and provide guidance for the interpretation of research based on the GWECB data.
Process for accessing GWECB data and specimens
The data and specimens (DNA, buffy coat, and plasma) from this pilot study are part of a data and specimen repository that is being managed by the VA Cooperative Studies Program Epidemiology Center in Durham, North Carolina (where the study Abbreviations: AIDS, acquired immunodeficiency syndrome; BPH, benign prostatic hyperplasia; GERD, gastroesophageal reflux disease; HIV, human immunodeficiency virus; VHA, Veterans Health Administration.
a Cell counts less than 5 are suppressed to protect privacy. b The original wording from the survey is shown. Totals for each health grouping (circulatory system problems, cancer, etc.) include the number and percentage of participants who responded "yes" for at least 1 diagnosis assessed under that grouping in the Gulf War Era Cohort and Biorepository survey. Refer to Web Table 4 for a list of all diagnoses associated with each health grouping. Diagnoses of male-only conditions are separated from their corresponding health groupings and presented at the bottom of the table.
c Six questions in the "other conditions" grouping provided text boxes, allowing participants to write in responses for other conditions they had been told they had. From 774 written-in responses, over 300 unique diagnoses were identified. The majority of these diagnoses had a prevalence of less than 5, and some had already been assessed as part of survey questions under other health groupings. Diagnoses that were written in text boxes are not reflected in these tabulations. d The table is sorted by the top 3 diagnoses within each health grouping for the full cohort (i.e., "total" column). Generally, the top 3 diagnoses for both VHA nonusers and VHA users had the same ranking as the top 3 diagnoses for the full cohort. In 3 cases, rank order did not match across all of the columns; thus, one of the columns may not be sorted in descending order and/or a fourth diagnosis is listed so that the top 3 diagnoses for all columns are included.
e Twelve participants did not respond to the survey questions used to determine VHA user status; their responses are captured in the "total" column.
f Percentages were calculated relative to all participants, such that the denominator (n = 1,275) included missing data. See Web Table 4 for a comprehensive tabulation of survey responses, including frequencies of missing data.
g The cancer grouping total does not include participants who reported being diagnosed with skin cancer and/or prostate cancer.
h This question provided a text box with the prompt "If yes, specify type." Close to 200 unique diagnoses were provided by participants via written-in responses. See footnote "c" regarding data from write-in responses.
was coordinated). Additional materials for facilitating future research are also available, including data dictionaries, authorizations for study staff to access VA and non-VA medical records, and authorizations for study staff to access data and biospecimens from other VA and non-VA studies. As we noted above, cohort participants also granted permission to be recontacted by study staff about additional research opportunities. Investigators who are interested in accessing GWECB data and/or specimens or in drawing on the additional resources of the project are invited to submit an application to the repository's Scientific and Ethical Oversight Committee and the repository administrator for review (23) . Once a proposal has been approved by the committee and administrator, has institutional review board approvals, and has data use agreements in place, the materials may be transferred to the investigator using secure and trackable mechanisms. Investigators agree to return new data and analysis code generated by substudies to the Data and Specimen Repository for use by other investigators under approved protocols.
In summary, the GWECB resource, built on a platform of quality and transparency, will support a variety of future research to better understand the health issues faced by veterans of the 1990-1991 Gulf War era and other veterans. This research will support the discovery of new and improved approaches to address the health concerns of these veterans. Additionally, lessons learned from this pilot study will inform recruitment processes for future research projects involving this population.
